(Press-News.org) As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs. Yet a new systematic review and meta-analysis published today in the British Journal of Sports Medicine found that cardiorespiratory fitness was a stronger predictor of both cardiovascular disease and all-cause mortality than BMI.
The researchers found that fit individuals across all BMI categories had statistically similar risks of death from all causes or cardiovascular disease. By contrast, unfit individuals in all BMI categories showed two- to three-fold higher risks of both all-cause and cardiovascular disease mortality compared with normal weight fit individuals. In fact, obese fit individuals had significantly lower risk of death compared to normal weight unfit individuals.
“Fitness, it turns out, is far more important than fatness when it comes to mortality risk,” said Siddhartha Angadi, associate professor of exercise physiology at the University of Virginia School of Education and Human Development and corresponding author of the study. “Our study found that obese fit individuals had a risk of death that was similar to that of normal weight fit individuals and close to one-half that of normal weight unfit individuals.
“Exercise is more than just a way to expend calories. It is excellent ‘medicine’ to optimize overall health and can largely reduce the risk of cardiovascular disease and all-cause death for people of all sizes.”
The researchers reviewed 20 studies with a total sample size of 398,716 adults from multiple countries. About one third of the participants in the studies were females, an increase of nearly three-fold from previous studies. In the majority of studies, individuals were classified as fit if their exercise stress test score (estimated or directly measured VO2max) placed them above the 20th percentile within their age group.
Obesity is associated with a series of health conditions and weight loss has long been seen as the way to reduce the impact of those conditions. But weight loss is challenging and failing to keep weight off can bring other risks.
“Most people who lose weight regain it,” said Glenn Gaesser, professor at Arizona State University and co-author of the study. “Repetitive cycles of losing and gaining weight—yo-yo dieting—is associated with numerous health risks comparable to those of obesity itself. Improving cardiorespiratory fitness may help avoid the adverse health effects associated with chronic yo-yo dieting.”
Approximately 20% of US adults meet the physical activity guidelines set by the U.S. Department of Health and Human Services. Current guidelines recommend adults perform a minimum of 150 minutes per week of moderate-intensity physical activity or 75-minutes of vigorous physical activity along with muscle strengthening for two days a week. For those who find themselves in the bottom 20th percentile of cardiorespiratory fitness, beginning any kind of aerobic exercise could have a big impact.
“The largest reduction in all-cause and cardiovascular disease mortality risk occurs when completely sedentary individuals increase their physical activity modestly,” Angadi said. “This could be achieved with activities such as brisk walking several times per week with the goal of accumulating approximately 30 minutes per day.”
The researchers note that the study examines data from large epidemiological studies and recommend that it is time to independently assess the value of a fitness-based approach rather than a weight-loss approach in obese individuals to optimize health outcomes.
Author Contact:
Siddhartha Angadi
University of Virginia
ssa2w@virginia.edu
Glenn Gaesser
Arizona State University
Glenn.gaesser@asu.edu
Press Contacts:
Marshall Eckblad
nuy2uz@virginia.edu
Tiffany Tolson
tmc5fy@virginia.edu
END
Research: Fitness more important than fatness for a lower risk of premature death
Individuals classified as fit—even when overweight or obese—showed no significant increase in cardiovascular disease or all-cause mortality.
2024-11-19
ELSE PRESS RELEASES FROM THIS DATE:
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses
2024-11-19
LA JOLLA, CA—In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia and even death.
Vaccines against both viruses, however, have been difficult to design. Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, ...
New study highlights physician perspectives on emerging anti-amyloid treatments for Alzheimer’s disease in Israel
2024-11-19
November 19, 2024 - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – In a recent study, Tel Aviv Sourasky Medical Center has shed light on physician attitudes toward novel anti-amyloid treatments (ATT) for Alzheimer’s disease (AD), revealing a spectrum of opinions across key specialties. With Israel’s health system structured to provide universal healthcare, the high out-of-pocket costs for new AD therapies have raised questions among medical professionals about the feasibility and practicality of implementing these treatments.
The study, conducted ...
U of M research finds creativity camp improves adolescent mental health, well-being
2024-11-19
MINNEAPOLIS/ST. PAUL (11/19/2024) — Published in Child Psychiatry and Human Development, a research team led by the University of Minnesota Medical School found that Creativity Camp, a two-week arts intervention delivered as a day camp, had a positive impact on mental health and well-being in adolescents with depression.
The idea behind the study is that engaging in the arts offers a pathway for exploring and expanding new ways of thinking, developing insights and sparking self-discovery.
“As a clinician, I am deeply aware of the urgent need for new treatment options for teens with depression. The findings in this report are promising, and I hope they ...
How human brain functional networks emerge and develop during the birth transition
2024-11-19
Brain-imaging data collected from fetuses and infants has revealed a rapid surge in functional connectivity between brain regions on a global scale at birth, possibly reflecting neural processes that support the brain’s ability to adapt to the external world, according to a study published November 19th, in the open-access journal PLOS Biology led by Lanxin Ji and Moriah Thomason from the New York University School of Medicine, USA.
Understanding the sequence and timing of brain functional network ...
Low-dose ketamine shows promise for pain relief in emergency department patients
2024-11-19
Des Plaines, IL — A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the October issue of Academic Emergency Medicine (AEM), the peer-reviewed journal of the Society for Academic Emergency Medicine (SAEM).
The study, titled Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use highlights the potential of low-dose ketamine as a valuable tool in pain management, providing a safe and effective option for emergency medicine physicians managing acute pain.
Pain remains one of the most common and challenging complaints ...
Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care
2024-11-19
Research Highlights:
A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care (education pamphlets about healthy diet and exercise), followed a lifestyle/risk factor modification program, or took metformin and followed a lifestyle/risk factor modification program.
AFib burden, a measure of how much time a patient experiences atrial arrhythmia, improved during the treatment period — particularly in the standard of care and lifestyle risk factor modification groups.
Lifestyle and risk factor modification was associated ...
Researchers discover new cognitive blueprint for making and breaking habits
2024-11-19
Cognitive neuroscientists in Trinity College Dublin have published new research describing a brand new approach to making habit change achievable and lasting.
This innovative framework has the potential to significantly improve approaches to personal development, as well as the clinical treatment of compulsive disorders (for example obsessive compulsive disorder, addiction, and eating disorders).
The research was led by Dr Eike Buabang, Postdoctoral Research Fellow in the lab of Professor Claire Gillan in the School of Psychology and has been published as a paper, Leveraging ...
In a small international trial, novel oral medication muvalaplin lowered Lp(a)
2024-11-19
Research Highlights:
The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited risk factor for cardiovascular disease.
Muvalaplin is a small molecule inhibitor that prevents the bonding of the two protein components that combine to make Lp(a). There are no currently FDA-approved medications to lower Lp(a) levels, though other medications are currently being evaluated in clinical trials. Muvalaplin is the first oral medication developed to lower Lp(a) levels.
Results ...
Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
2024-11-19
WEST LAFAYETTE, Ind. — Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
A single intranasal dose of EV25, a bispecific small molecule developed by Eradivir, acts faster than the current standard of care, eliminating the detectable virus within 24 hours. EV25 also has a window of efficacy of 96 hours postinfection, which is broader than the current standard of care.
A ...
Most Medicare beneficiaries do not compare prescription drug plans – and may be sticking with bad plans
2024-11-19
Every fall, millions of Medicare beneficiaries have the chance to pick a new stand-alone prescription drug plan that may be better suited for them, but most stick with the same plan.
A new study published today in Health Affairs Scholar suggests that 52% of Medicare beneficiaries with stand-alone Part D plans did not switch because they made no plan comparisons at all for 2024. Many of these beneficiaries (41%) also reported not knowing how to switch plans.
“Comparing these Medicare Part D plans is hard, so many beneficiaries just don’t do it. But beneficiaries who don’t compare plans may not notice if they are sticking with more expensive plans or ...
LAST 30 PRESS RELEASES:
New initiative launched to improve care for people with certain types of heart failure
You’ve never seen corn like this before
Mediterranean diet could reduce gum disease
Mount Sinai launches cardiac catheterization artificial intelligence research lab
Why AI is never going to run the world
Stress in the strands: Hair offers clues to children’s mental health
UCLA distinguished professor, CVD researcher to receive 2025 Basic Research Prize
UT San Antonio School of Public Health: The People’s School
‘Preventable deaths will continue’ without action to make NHS more accessible for autistic people, say experts
Scientists shoot lasers into brain cells to uncover how illusions work
Your ecosystem engineer was a dinosaur
New digital cognitive test for diagnosing Alzheimer's disease
Parents of children with health conditions less confident about a positive school year
New guideline standardizes consent for research participants in Canada
Research as reconciliation: Oil sands and health
AI risks overwriting history and the skills of historians have never been more important, leading academic outlines in new paper
The Lancet Diabetes & Endocrinology: Higher doses of semaglutide can safely enhance weight loss and improve health for adults living with obesity, two new clinical trials confirm
Trauma focused therapy shows promise for children struggling with PTSD
School meals could drive economic growth and food system transformation
Home training for cerebellar ataxias
Dry eyes affect over half the general population, yet only a fifth receive diagnosis and treatment
Researchers sound warning about women with type 2 diabetes taking oral HRT
Overweight and obesity don’t always increase the risk of an early death, Danish study finds
Cannabis use associated with a quadrupling of risk of developing type 2 diabetes, finds study of over 4 million adults
Gestational diabetes linked to cognitive decline in mothers and increased risk of developmental delays, ADHD and autism among children
Could we use eye drops instead of reading glasses as we age?
Patients who had cataracts removed or their eyesight corrected with a new type of lens have good vision over all distances without spectacles
AI can spot which patients need treatment to prevent vision loss in young adults
Half of people stop taking popular weight-loss drug within a year, national study finds
Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds
[Press-News.org] Research: Fitness more important than fatness for a lower risk of premature deathIndividuals classified as fit—even when overweight or obese—showed no significant increase in cardiovascular disease or all-cause mortality.